|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
09886 DINGDANG HEALTH
Nominal 
1.180 +0.020 (+1.724%) | 2025/06 - Interim RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | (11,352) | (5,237) | (237,871) | (295,490) |
| Net Cash from / (used in) Investing Activities | -- | 156,959 | 104,324 | (353,416) | 306,635 |
| Net Cash from / (used in) Financing Activities | -- | (121,370) | (130,537) | 232,896 | 1,271,553 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 24,237 | (31,450) | (358,391) | 1,282,698 |
| Cash & Cash Equivalents at beginning of period | -- | 1,185,898 | 1,210,949 | 1,552,994 | 260,574 |
| Effect of Foreign Exchange Rate Changes | -- | 7,819 | 6,399 | 16,346 | 9,722 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 1,217,954 | 1,185,898 | 1,210,949 | 1,552,994 |
| Remarks: | Real time quote last updated: 28/10/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -51,671 |
| %Change | -38.844% |
| EPS / (LPS) | RMB -0.040 |
| NBV Per Share (¥) | RMB 1.255 |